Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.970
-0.050 (-2.48%)
Dec 4, 2025, 4:00 PM EST - Market closed
Celularity Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| 40.58 | 54.22 | 22.77 | 17.98 | 21.34 | 14.28 | Upgrade | |
Revenue Growth (YoY) | -15.81% | 138.11% | 26.68% | -15.75% | 49.43% | -32.48% | Upgrade |
Cost of Revenue | 20.04 | 14.99 | 16.02 | 19.67 | 9.65 | 4.93 | Upgrade |
Gross Profit | 20.54 | 39.23 | 6.76 | -1.69 | 11.68 | 9.35 | Upgrade |
Selling, General & Admin | 52.26 | 58.64 | 50.58 | 66.02 | 62.21 | 31.34 | Upgrade |
Research & Development | 15.51 | 17.39 | 30.47 | 78.36 | 84.97 | 52.71 | Upgrade |
Amortization of Goodwill & Intangibles | 1.44 | 1.75 | 2.19 | 2.19 | 2.19 | 3.39 | Upgrade |
Operating Expenses | 69.21 | 77.78 | 83.23 | 146.58 | 149.37 | 87.44 | Upgrade |
Operating Income | -48.67 | -38.55 | -76.48 | -148.27 | -137.69 | -78.09 | Upgrade |
Interest Expense | -7.67 | -6.26 | -3.02 | - | -3.17 | -2.35 | Upgrade |
Interest & Investment Income | 0.28 | 0.33 | 0.32 | 0.37 | 0.33 | 0.37 | Upgrade |
Other Non Operating Income (Expenses) | -17.7 | -9.2 | -0.13 | 41.96 | 11.8 | -54.59 | Upgrade |
EBT Excluding Unusual Items | -73.77 | -53.69 | -79.3 | -105.94 | -128.72 | -134.67 | Upgrade |
Merger & Restructuring Charges | - | - | - | - | -7.19 | - | Upgrade |
Impairment of Goodwill | - | - | -112.35 | -3.61 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | - | -4.43 | Upgrade |
Asset Writedown | - | - | - | - | - | -129.4 | Upgrade |
Legal Settlements | - | - | - | - | -5.33 | - | Upgrade |
Other Unusual Items | -6.88 | -4.21 | 103.16 | 123.76 | 41.15 | 55.57 | Upgrade |
Pretax Income | -80.65 | -57.89 | -196.29 | 14.21 | -100.1 | -212.93 | Upgrade |
Income Tax Expense | - | - | 0.01 | 0.01 | 0.02 | -4.7 | Upgrade |
Net Income | -80.65 | -57.89 | -196.3 | 14.19 | -100.12 | -208.23 | Upgrade |
Net Income to Common | -80.65 | -57.89 | -196.3 | 14.19 | -100.12 | -208.23 | Upgrade |
Shares Outstanding (Basic) | 24 | 22 | 18 | 14 | 7 | 2 | Upgrade |
Shares Outstanding (Diluted) | 24 | 22 | 18 | 15 | 7 | 2 | Upgrade |
Shares Change (YoY) | 13.94% | 22.89% | 18.89% | 123.44% | 264.09% | -22.85% | Upgrade |
EPS (Basic) | -3.35 | -2.64 | -11.02 | 1.01 | -14.93 | -113.06 | Upgrade |
EPS (Diluted) | -3.35 | -2.64 | -11.02 | 0.95 | -14.93 | -113.06 | Upgrade |
Free Cash Flow | -6.65 | -6.56 | -39.73 | -143.11 | -116.3 | -91.03 | Upgrade |
Free Cash Flow Per Share | -0.28 | -0.30 | -2.23 | -9.55 | -17.34 | -49.42 | Upgrade |
Gross Margin | 50.61% | 72.36% | 29.67% | -9.40% | 54.75% | 65.46% | Upgrade |
Operating Margin | -119.95% | -71.10% | -335.86% | -824.85% | -645.35% | -546.93% | Upgrade |
Profit Margin | -198.75% | -106.77% | -862.04% | 78.95% | -469.27% | -1458.42% | Upgrade |
Free Cash Flow Margin | -16.38% | -12.10% | -174.49% | -796.17% | -545.11% | -637.53% | Upgrade |
EBITDA | -41.36 | -30.63 | -67.16 | -138.83 | -128.87 | -69.92 | Upgrade |
EBITDA Margin | -101.92% | -56.49% | -294.91% | - | - | - | Upgrade |
D&A For EBITDA | 7.32 | 7.92 | 9.32 | 9.44 | 8.82 | 8.17 | Upgrade |
EBIT | -48.67 | -38.55 | -76.48 | -148.27 | -137.69 | -78.09 | Upgrade |
EBIT Margin | -119.95% | -71.10% | - | - | - | - | Upgrade |
Effective Tax Rate | - | - | - | 0.09% | - | - | Upgrade |
Revenue as Reported | 40.58 | 54.22 | 22.77 | 17.98 | 21.34 | 14.28 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.